About AST

Transplant News

September, 2020

September 16, 2020
SRTR is excited to announce the launch of our new, interactive, mobile-friendly program-specific reports (PSRs) and organ procurement organization-specific ... Read More...
September 09, 2020
At its meeting on August 19th, the AST Board of Directors approved a new membership category for Non-Medical doctoral degree holders with a $250 dues cost and an available optional AJT subscription.  Members eligible for this category include holders of PhD, PharmD, PsyD, DNP, and other doctoral-level degrees without an accompanying medical degree (MD, DO, MBBS, etc.).   This new category, which will apply to approximately 650 AST members, was created in response to results of the recent Membership Value and Dues Survey as well as ongoing feedback from this group.  The Board recognizes that... Read More...
September 03, 2020
1.     ... Read More...
September 03, 2020
Our dear friend and colleague, John S. Najarian, passed away on September 1, 2020. He was an esteemed colleague, a talented scientist and a pioneer in the field of transplantation. Dr. Najarian was an incredibly successful and innovative organ-transplant surgeon and served as Chairman of the Department of Surgery at the University of Minnesota from 1967 until 1993. Dr. Najarian's legacy covers a number of areas including kidney transplants for Type 1 diabetes, pediatric transplantation and pioneering islet cell transplants, among many other things. Dr. Najarian and his team contributed... Read More...
September 01, 2020
The AST was saddened to hear about the recent passing of transplant surgeon, George Melville Williams, MD (1930 – 2020). Dr. Williams passed away on August 26, 2020, at the age of 89. Dr. Williams initiated a transplantation program and became Chief of Transplantation and Vascular Surgery at Johns Hopkins. He also held leadership roles in several medical societies, which included being the first UNOS president and a former president of the American Society of Transplant Surgeons. View Dr. Williams' full obituary... Read More...

August, 2020

August 07, 2020
In light of the current global pandemic, the Scientific Registry of Transplant Recipients (SRTR) will be modifying the evaluation metrics for transplant programs and organ procurement organizations. Following the declaration of a national public health emergency on March 13, 2020, COVID-19 has had a large impact on the transplant system. The reports scheduled for release in January 2021, with data presented through June 30, 2020, will be the first to cover the performance period after March 13, 2020. The SRTR ... Read More...

July, 2020

July 28, 2020
The Centers for Medicare & Medicaid Services today released its first monthly update of data that provides a snapshot of the impact of COVID-19 on the Medicare population. For the first time, the snapshot includes data for American Indian/Alaskan Native Medicare beneficiaries. The new data indicate that American Indian/Alaskan Native beneficiaries have the second highest rate of hospitalization for COVID-19 among racial/ethnic groups after Blacks. Previously, the number of hospitalizations of American Indian/Alaskan Native beneficiaries was too low to be reported. The updated data... Read More...
July 20, 2020
The full House Committee on Energy and Commerce unanimously passed H.R. 5534, the Comprehensive Drug Coverage for Kidney Transplant Patients Act (referred to as the "Immuno Bill"). Prior to the unanimous Committee vote on July 15, 2020. Congressman Dr. Michael Burgess (R-TX) made remarks publicly recognizing the work of the American Society of Transplantation (AST), the American Society of Transplant Surgeons (ASTS), and American Association of Kidney Patients (AAKP). Congressman Burgess further requested that a joint letter of support from AST, ASTS, and AAKP be entered into the official... Read More...

June, 2020

June 30, 2020
As a fundamental extension of the AST mission, we stand resolute in our commitment to eradicate systemic racism in all forms, eliminate racial disparities, elevate collegial diversity, deconstruct barriers to a culture of racial equality, and hold the transplant community accountable to zero-tolerance for racism. While recent tragic events in the Black community have catalyzed our society, we recognize the longstanding and historical patterns of neglect, abuse, and maltreatment perpetrated on people of color, especially Black Americans. We unequivocally affirm that Black lives matter.... Read More...
June 17, 2020
Critical Path Institute(C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the iBox Scoring System (Composite Biomarker Panel) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP). The iBox Scoring System is a risk prediction... Read More...

Pages